| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $116.45 | $23.94 | 386.50% | 219.72x | 55.42x | 14.77x | 17.84x | 1.59x | $106.92M | 0.87% | $705.78M | 6.70 | $12.49B | 1,591.64 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $32.82 | $8.21 | 299.94% | 156.29x | 74.51x | 9.23x | 18.70x | 1.33x | $39.15M | 0.91% | $220.58M | 1.69 | $4.20B | 92.63 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $83.17 | $17.27 | 381.58% | 77.73x | 71.15x | 7.67x | 9.92x | 1.98x | $182.84M | 2.83% | $654.15M | 8.43 | $6.32B | 52.71 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $230.71 | $82.62 | 179.23% | 37.82x | 34.75x | 6.42x | 22.80x | 1.24x | $793.95M | 2.58% | $1.35B | 10.14 | $32.15B | 27.26 | ||
| HALO | HALOZYME THERAPEUTICS INC | $124.37 | $71.29 | 74.47% | 34.94x | 13.74x | 8.77x | 98.34x | 0.67x | $806.22M | 5.53% | $143.54M | 1.22 | $16.10B | 22.41 | ||
| KRYS | KRYSTAL BIOTECH INC | $325.42 | $82.99 | 292.11% | 39.35x | 42.33x | 21.82x | 7.09x | 2.13x | $257.78M | 2.68% | $1.36B | 46.03 | $9.21B | 39.49 | ||
| VCEL | VERICEL CORP | $40.58 | $7.96 | 409.89% | 84.54x | 72.50x | 6.77x | 5.62x | 2.07x | $61.66M | 2.97% | $370.04M | 7.25 | $2.05B | 46.43 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.44 | $18.71 | 201.70% | 148.53x | 20.47x | 3.20x | 1.73x | 0.98x | $738.18M | 6.76% | $6.32B | 32.68 | $14.24B | 36.91 | ||
| RPRX | ROYALTY PHARMA PLC | $62.25 | $36.13 | 72.29% | 33.11x | 11.46x | 10.92x | 3.66x | 0.67x | $2.92B | 10.55% | $9.79B | 21.99 | $43.94B | 37.36 | ||
| TGTX | TG THERAPEUTICS INC | $54.53 | $22.94 | 137.70% | 17.70x | 54.39x | 9.67x | 13.82x | 1.83x | $17.39M | 0.23% | $604.08M | 4.26 | $8.62B | 61.89 | ||
| ADMA | ADMA BIOLOGICS INC | $11.23 | $6.95 | 61.67% | 15.60x | 14.12x | 5.00x | 6.16x | 0.91x | $116.47M | 4.54% | $408.21M | 1.79 | $2.58B | 11.06 | ||
| EXEL | EXELIXIS INC | $64.39 | $30.48 | 111.29% | 19.57x | 19.34x | 6.63x | 8.65x | 1.24x | $1.17B | 7.26% | $1.84B | 7.35 | $15.84B | 14.56 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $306.40 | $85.96 | 256.45% | 30.43x | 32.45x | 21.16x | 6.31x | 2.28x | $130.62M | 2.13% | $967.52M | 48.22 | $6.23B | 22.34 | ||
| MDXG | MIMEDX GROUP INC | $4.23 | $1.20 | 252.28% | 105.75x | -23.47x | 1.76x | 2.85x | 1.22x | $44.50M | 7.12% | $216.00M | 1.46 | $497.93M | 21.83 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $213.76 | $180.41 | 18.48% | 14.01x | 8.95x | 2.94x | 2.89x | 0.57x | $1.62B | 11.99% | $4.80B | 75.98 | $16.65B | 10.30 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.47 | $7.58 | 38.19% | 11.02x | 9.62x | 4.55x | 2.86x | 0.96x | $82.01M | 13.24% | $217.65M | 3.68 | $477.92M | 6.18 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $514.65 | $147.61 | 248.66% | 29.70x | 26.94x | 10.37x | 6.44x | 2.23x | $3.80B | 2.91% | $20.25B | 79.81 | $126.28B | 22.95 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.70 | $30.71 | 26.03% | 12.32x | 9.28x | 2.34x | 2.26x | 0.70x | $354.90M | 15.83% | $999.24M | 17.25 | $1.86B | 6.64 | ||
| UTHR | UNITED THERAPEUTICS CORP | $553.88 | $187.64 | 195.17% | 18.32x | 20.49x | 7.48x | 3.71x | 3.37x | $1.09B | 4.63% | $6.40B | 150.24 | $21.95B | 13.09 | ||
| TECH | BIO-TECHNE CORP | $72.58 | $16.24 | 346.97% | 62.03x | 34.93x | 9.32x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.41B | 32.81 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $807.48 | $427.53 | 88.87% | 19.25x | 13.82x | 5.34x | 2.62x | 1.01x | $3.76B | 4.53% | $31.71B | 308.48 | $83.38B | 14.50 | ||
| VCYT | VERACYTE INC | $44.79 | $11.86 | 277.62% | 31.10x | 23.04x | 6.37x | 2.59x | 2.52x | $165.99M | 4.63% | $1.39B | 17.36 | $3.34B | 23.91 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.22 | $1.38 | -11.71% | 8.71x | -2.75x | 1.50x | 1.61x | 0.49x | $19.58M | 27.70% | $44.20M | 0.76 | $22.32M | 2.92 | ||
| INCY | INCYTE CORP | $116.62 | $57.36 | 103.30% | 14.36x | 34.69x | 4.02x | 3.73x | 1.72x | $1.92B | 8.22% | $6.34B | 31.66 | $19.69B | 9.52 |